Multicentre phase II and pharmacokinetic study of RFS2000 (9-nitro-camptothecin) administered orally 5 days a week in patients with glioblastoma multiforme

✍ Scribed by E. Raymond; M. Campone; R. Stupp; J. Menten; P. Chollet; T. Lesimple; R. Fety-Deporte; D. Lacombe; X. Paoletti; P. Fumoleau

• Book ID: 117658920
• Publisher: Elsevier Science
• Year: 2002
• Tongue: English
• Weight: 74 KB
• Volume: 38
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/s0959-8049(02)00070-9